Case Presentations

To fully appreciate the complexity and challenges in interpreting hypertension trials, it is informative to review their evolution. The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.

The early clinical trials had the advantage of being able to compare active therapywith placebo and usually included patients with more severe hypertension, as compared with modern trials. Consequently, they generated more end points and had sufficient power to be conducted on a smaller scale than modern trials high blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

  • Integrating lifestyle advice into clinical management
  • Meta-analysis of blood pressure-lowering drug trials
  • Reporting blood pressure parameters in clinical trails
  • Surrogate or intermediate disease markers
  • Primary biliary cirrhosis

Related Conference of Case Presentations

April 29 - May 01, 2019

4th World Heart Congress

Kyoto, Japan
June 17-19, 2019

31st Annual Cardiologists Conference

Rome, Italy
Venue: Holiday Inn Rome Aurelia
July 01-02, 2019

European Cardiology Congress

Prague, Czech Republic
July 10-11, 2019

25th World Cardiology Conference

Osaka, Japan
July 10-11,2019

26th Annual Cardiologists Conference

Osaka,Japan
July 22-23, 2019

World Cardiology Experts Meeting

Kyoto Japan
July 26-27, 2019

4th International Conference on Hypertension and Healthcare

Melbourne, Australia
July 26-27, 2019 |

27th International Conference & Exhibition on Cardiology and Cardiovascular Medicine

The Westin Miyako Kyoto | Kyoto, Japan
July 31-August 01, 2019

27th International Congress on Cardiology and Medical Interventions

Chicago, Illinois, USA
August 12-13, 2019

2nd International Conference on Cardiovascular Diseases and Therapeutics

| Amsterdam, The Netherlands
August 15-16, 2019

2nd Global Cardiology Summit

Bangkok, Thailand
August 19-20, 2019

7th World Heart Congress

Vienna, Austria
September 23-24, 2019

World Congress on Cardiac Surgery & Medical Devices 2019

Barcelona, Spain
September 26-27, 2019

7th World Congress on Hypertension and Public Health

Lisbon, Portugal
Semptember 26-27, 2019

World Congress on Congestive Heart Failure & Angina

Paris | France
September 26-27, 2019

World Cardiology Meeting

| Florence, Italy
October 23-24, 2019

European Heart Congress

Prague, Czech Republic
October 24-26, 2019

32nd European Cardiology Conference

Zurich, Switzerland
November 04-05, 2019

Annual Congress on Pediatric Cardiology 2019

Tokyo, Japan
November 25-26, 2019

2nd World Heart Rhythm Conference

Dubai, UAE
November 25-26, 2019

33rd World Congress on Cardiology & Heart Diseases

Rome, Italy
December 02-03, 2019

34th World Cardiology Conference

Madrid, Spain
December 09-10, 2019

2nd World Heart and Brain Conference

Abu Dhabi, UAE
March 09-10, 2020

2nd Middle East Heart Congress

Abu Dhabi, UAE
March 26-27, 2020

8th World Heart Congress

April 20-21, 2020

Global Summit on Heart Diseases

Tokyo | Japan

Case Presentations Conference Speakers

Recommended Sessions

Related Journals

Are you interested in